A Phase 1b Study of Botensilimab and Balstilimab in Treatment-Refractory Hepatocellular Carcinoma. - El-Khoueiry AB; Lieu CH; Abou-Alfa GK; Tsimberidou AM; Mahadevan D; Hanna DL; Bockorny B; Wilky BA; Leal A; Stebbing J; Avagyan M; Wu W; et al. (Liver cancer, 2026)